+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ergotamine"

Migraine Drugs Global Market Report 2024 - Product Thumbnail Image

Migraine Drugs Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Ergotamine is a drug used to treat migraine headaches. It is a member of the class of drugs known as Central Nervous System (CNS) drugs, which are used to treat a variety of neurological conditions. Ergotamine works by constricting the blood vessels in the brain, reducing the pain associated with migraine headaches. It is usually taken orally, but can also be administered intravenously or intramuscularly. Ergotamine is available in both prescription and over-the-counter forms. It is often used in combination with other medications, such as anti-nausea drugs, to provide relief from migraine headaches. Common side effects of ergotamine include nausea, vomiting, dizziness, and drowsiness. The ergotamine market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Other companies that produce ergotamine include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more